The entry into cells of Newcastle disease virus (NDV), a prototype member of the paramyxoviruses, is believed to occur by direct fusion at the plasma membrane through a pH-independent mechanism. In addition, NDV may enter host cells by an endocytic pathway. Treatment of cells with drugs that block caveolae-dependent endocytosis reduced NDV fusion and infectivity, the degree of inhibition being dependent on virus concentration. The inhibitory effect was reduced greatly when drugs were added after virus adsorption. Cells treated with methyl b-cyclodextrin, a drug that sequesters cholesterol from membranes, reduced the extent of fusion, infectivity and virus-cell binding; this indicates that cholesterol plays a role in NDV entry. Double-labelling immunofluorescence assays performed with anti-NDV monoclonal antibodies and antibodies against the early endosome marker EEA1 revealed the localization of the virus in these intracellular structures. Using fluorescence microscopy, it was found that cell-cell fusion was enhanced at low pH. It is concluded that NDV may infect cells through a caveolae-dependent endocytic pathway, suggesting that this pathway could be an alternative route for virus entry into cells.
INTRODUCTION
Newcastle disease virus (NDV) is one of the causes of avian respiratory diseases and economic losses in the poultry industry. It is a member of the family Paramyxoviridae, which includes enveloped, negative-stranded RNA viruses that encode two transmembrane glycoproteins: an attachment protein, HN, and a fusion protein or F protein. Virus adsorption occurs at the surface of the host cell membrane. The viral attachment protein HN recognizes and binds to sialic acid-containing molecules such as glycoproteins and glycolipids (Ferreira et al., 2004) and has neuraminidase and fusion-promoting activities. Following binding, the F protein promotes fusion between the viral and cellular membranes and the viral genome is delivered into the cytoplasm.
Enveloped viruses enter the cell through two main pathways: direct fusion between the viral envelope and the plasma membrane; and receptor-mediated endocytosis. In the case of paramyxoviruses, it has been established that the membrane fusion process takes place at the host plasma membrane in a pH-independent manner. Despite this, it has been shown previously that fusion of NDV with cultured cells is enhanced at acidic pH (San Roman et al., 1999) , leading us to propose that NDV may also penetrate the cell via an endocytic pathway in a pH-dependent process.
After binding of an enveloped virus to its cognate receptor at the cell surface, membrane fusion is responsible for delivery of the nucleocapsid into the cytoplasm. Receptor binding and low pH have been considered to be the two main triggering mechanisms responsible for conformational changes in viral envelope glycoproteins leading to fusion. Also, it has been shown that in the recently emerged paramyxoviruses Nipah virus and Hendra virus, activation of the F protein is accomplished by proteolysis after endocytic entry (Diederich et al., 2005; Meulendyke et al., 2005) , similarly to the activation of the Ebola virus glycoprotein (Chandran et al., 2005) and the spike glycoprotein of severe acute respiratory syndrome coronavirus (Simmons et al., 2005) . For pH-independent viruses such as retroviruses or paramyxoviruses, activation of the fusion protein occurs through interaction of the viral glycoproteins with the receptor (Eckert & Kim, 2001 ). For pH-dependent viruses such as togaviruses, rhabdoviruses, orthomyxoviruses, alphaviruses and flaviviruses, low pH triggers conformational changes after internalization into endosomes (Lamb, 1993; Marsh & Helenius, 1989; White et al., 1983) . Recently, a new activation mechanism has emerged, as described for the retrovirus avian sarcoma and leukosis virus, in which the trigger needs a combination of both mechanisms: an initial binding to receptors at neutral pH, which then renders the viral glycoprotein sensitive to low pH activation (Matsuyama et al., 2004; Melikyan et al., 2004; Mothes et al., 2000) .
The endocytic pathways used by animal viruses to enter host cells include macropinocytosis, phagocytosis, the clathrinand caveolae-dependent pathways and some less wellcharacterized routes called the non-clathrin-, non-caveolaedependent pathways (Conner & Schmid, 2003; Pelkmans & Helenius, 2003; Sieczkarski & Whittaker, 2002a; Marsh & Helenius, 2006) . Clathrin coats are known to be involved in the entry of numerous enveloped and non-enveloped viruses, e.g. the alphaviruses Semliki Forest virus and Sindbis virus (DeTulleo & Kirchhausen, 1998; Marsh & Helenius, 1980) , rhabdoviruses such as vesicular stomatitis virus (Matlin et al., 1982; Sun et al., 2005) , influenza viruses (Matlin et al., 1981; Roy et al., 2000) , adenoviruses (Bartlett et al., 2000) , parvoviruses , JC polyomavirus (Pho et al., 2000) , picornaviruses Joki-Korpela et al., 2001 ) and bunyaviruses (Jin et al., 2002) . Caveolae are small, flask-shaped invaginations in the plasma membrane with high levels of cholesterol and glycosphingolipids and the integral membrane protein caveolin. These structures are used for the internalization of viruses such as simian virus 40 (SV-40) (Anderson et al., 1996; Pelkmans et al., 2001 ). The picornavirus echovirus 1 (Marjomaki et al., 2002) , Ebola virus (Empig & Goldsmith, 2002) and BK polyomavirus (Eash et al., 2004) have also been reported to enter via caveolae. It has been proposed that murine polyomavirus enters cells through non-clathrin-, non-caveolae-dependent pathways (Gilbert & Benjamin, 2000) . Additionally, the human enterovirus EV-11 uses a novel entry pathway that is dependent on lipid rafts (Stuart et al., 2002) , and rotaviruses may infect cells in a cholesterol-and dynamin-dependent, but clathrin-and caveolae-independent manner (SanchezSan Martin et al., 2004) . In addition to clathrin-dependent entry, the internalization of influenza virus through a nonclathrin-dependent pathway has also been reported (Sieczkarski & Whittaker, 2002b) .
The acidic pH activation of the fusion activity of NDV and the partial blocking effect of lysosomotropic agents on NDV fusion have been reported previously (San Roman et al., 1999) . In the present study, the suggestion that endocytosis might play a role in NDV entry is addressed directly. Different approaches were used to dissect the entry mechanism of NDV, i.e. utilization of drugs that specifically disrupt the clathrin-or caveolae-dependent pathways and studies of the co-localization of NDV with markers of the endosomal network. In addition to pH-independent fusion with the plasma membrane, our results seem to point to the use of the caveolae-endocytic route by NDV, which delivers virus particles to early endosomes.
METHODS
Reagents and antibodies. Chlorpromazine, phorbol 12-myristate 13-acetate (PMA), methyl b-cyclodextrin (MbCD) and nystatin were from Sigma. CMFDA, CMPTX, octadecylrhodamine B chloride (R18), Hoechst 33258, Alexa fluor 488 donkey anti-mouse IgG and Alexa fluor 568 rabbit anti-goat IgG were from Molecular Probes. Monoclonal antibodies against NDV HN protein (anti-HN mAb) and against respiratory syncytial virus (RSV) F protein (22A4) were a generous gift from A. García-Sastre (Mount Sinai School of Medicine, New York). Goat polyclonal anti-EEA1 antibody was from Santa Cruz Biotechnology.
Cells and viruses. The lentogenic 'Clone 30' strain of NDV was obtained from Intervet Laboratories. Virus was grown and purified mainly as described previously (Garcia-Sastre et al., 1989) . COS-7, HeLa and Vero cells were obtained from the ATCC and maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with L-glutamine (580 mg l 21 ), penicillin-streptomycin (100 U ml 21 -100 mg ml
21
) and heat-inactivated fetal bovine serum (FBS; 10 % for COS-7 and HeLa cells and 5 % for Vero cells).
NDV infection in cell culture and syncytia assays. At 12-24 h after plating, cells were infected with NDV at an m.o.i. of 1 in DMEM containing 2 % FBS. The virus was left to be adsorbed for 1 h at 37 uC. At 12 h post-infection (p.i.), trypsin digestion of the precursor F 0 was accomplished as described previously (Young et al., 1997) and cells were incubated for an additional 4-12 h. Cells were then fixed with methanol and stained with Giemsa. The number of syncytia (cells containing more than three nuclei) was determined in 20 random areas of the well.
Virus titration. Virus titres were calculated in plaque formation assays in Vero cells as described previously (San Roman et al., 2002) . Plaque numbers were counted under a light microscope; NDV infectivity was expressed as p.f.u. ml 21 .
Effect of drugs on NDV fusion and infection. At 12-24 h after plating, cells were pretreated with various concentrations of drugs (MbCD for 30 min and PMA, nystatin or chlorpromazine for 45 min). Cells were then infected as described above with NDV at different m.o.i. Drugs were maintained in the cultures throughout all incubation periods or removed before virus infection. Drugs were added after virus adsorption where stated. Cell viability was determined by Trypan blue exclusion. Viabilities of cells treated with PMA (10 mM) and nystatin (10 mg ml 21 ) were greater than 90 and 82 % for 45 min and 24 h drug treatment, respectively; those for MbCD (5 mM) were greater than 90 and 64 % for 30 min and 12 h drug treatment, respectively. For chlorpromazine, about 90 % cell viability was observed after 45 min with 5 mg chlorpromazine ml 21 . Owing to the notorious toxicity of this drug, longer periods of chlorpromazine treatment were not considered.
Virus binding assays. Purified NDV was labelled with the fluorescent probe octadecylrhodamine (R18) essentially as described previously (Hoekstra et al., 1984; San Roman et al., 1999) . R18-labelled NDV (R18-NDV; 20 mg) was allowed to bind to 3.5610 6 cells at 4 uC in 400 ml PBS, pH 7.4, over 20 min, stirring periodically. After incubation, unbound virus was removed by centrifugation at 1000 g for 5 min at 4 uC. The distribution of R18 between the cell pellet and supernatant, corresponding to bound and free virus, respectively, was determined after the addition of Triton X-100 at a final concentration of 1 % (v/v).
Immunofluorescence labelling and confocal microscopy.
HeLa cells grown on glass coverslips were untreated or pretreated with drugs at the stated concentrations as described above. Cells were then infected with NDV or RSV at an m.o.i. of 10 for 1 h. At 30 min p.i. (confocal assays) or 15 h p.i. (infectivity assays), cells were washed three times with PBS ++ (PBS containing 1 mM MgCl 2 and 0.1 mM CaCl 2 ) and fixed in 2.5 % paraformaldehyde for 30 min. Following this, cells were washed three more times with PBS ++ and permeabilized with 0.1 % Triton X-100 for 10 min. Cells were then incubated in blocking solution (PBS ++ containing 1 % BSA) for 30 min, after which they were incubated with primary antibody for 1 h (anti-HN mAb, dilution 1 : 200; goat anti-EEA1, dilution 1 : 100). After washing three times with PBS ++ , cells were incubated with the appropriate Alexa fluor-labelled secondary antibody for 45 min [Alexa fluor 488 donkey anti-mouse (1 mg ml 21 ) or Alexa fluor 568 rabbit anti-goat (10 mg ml 21 )]. Nuclei were stained with Hoechst 33258 (10 mg ml
). After washing with blocking solution and a short rinse in ultrapure water, cells were mounted in Mowiol and viewed with a confocal microscope (Zeiss LSM 510) equipped with a 488 nm argon laser and a 543 nm helium-neon laser (636 objective lens for co-localization assays and 406 objective lens for infectivity assays).
Cell-cell fusion assays. Target cells (non-infected COS-7 cells) were labelled with the cytoplasmic dye CMTPX (red emission; excitation/emission 577/602 nm) at a concentration of 10 mM for 45 min at 37 uC. At 12 h p.i., effector cells (NDV-infected COS-7 cells) were labelled with the cytosolic probe CMFDA (green emission; excitation/emission 492/517 nm) at a concentration of 10 mM for 45 min at 37 uC. After labelling, the two cell populations were mixed in the ratio 3 : 1 (effector : target) in complete medium and co-cultured for 3 h at 37 uC. The F 0 precursor was then proteolytically activated as described above and, immediately after, cells were incubated in PBS at different pH values for 1, 2, 5 or 10 min. The pH was returned to around neutral with complete medium and cells were incubated for an additional 2 h at 37 uC. Dye distribution was then monitored microscopically using an inverted Olympus IX51 microscope with the U-MNG2 filter cube for rhodamine probes and the U-MNB2 filter cube for fluorescein probes. The extent of fusion was calculated as the mean of a and b, where a is 1006(number of positive cells for both dyes/total number of cells positive for CMTPX) and b is 1006(number of positive cells for both dyes/total number of positive cells for CMFDA).
RESULTS

Effect of inhibitors of endocytosis on NDV infectivity, fusion and binding
To characterize further the entry mechanism of NDV into host cells, the effect of several inhibitors of clathrin-or caveolae-dependent endocytosis on NDV infectivity and fusion was analysed. Cells were pretreated in the presence of several concentrations of different drugs: PMA, an inhibitor of caveolae-mediated endocytosis that acts by constitutively phosphorylating caveolin (Anderson, 1993) ; nystatin, a steroid-binding antibiotic that is also used to inhibit caveolae uptake since cholesterol is important for caveola maintenance and dynamics (Anderson, 1993; Lisanti et al., 1993; Rothberg et al., 1990) ; and MbCD, a cholesterol-sequestering agent that depletes cholesterol in cell membranes, thus preventing the formation of both clathrin-coated vesicles and caveolae (Rodal et al., 1999; Subtil et al., 1999) . The cationic amphiphilic compound chlorpromazine, which prevents the recycling of clathrin (Hunt & Marshall-Carlson, 1986; Wang et al., 1993) , was used as a specific inhibitor of clathrin-mediated endocytosis. As can be seen from the data in Fig. 1 , pre-incubation of cells with PMA, nystatin or MbCD elicited a reduction in virus infectivity. This decrease was detected when the drugs were present throughout the incubation periods (Fig. 1a) and when they were removed before virus infection (Fig. 1b) , pointing to a specific effect of the drugs. Moreover, in some drug-treated cells, virus bound to the cell surface without entering the cell. However, when cells were treated with chlorpromazine, no decrease in virus infectivity was detected (Fig. 1b) . Additionally, the reduction in virus infectivity was quantified with a plaque reduction assay in Vero cells, as detailed in Methods. Cells treated with PMA (10 mM) and nystatin (10 mg ml
21
) showed a reduction of about 70 % in virus infectivity compared with the controls, whereas NDV infectivity in cells treated with MbCD (10 mM) was reduced by about 54 % (data not shown). These data were confirmed by those relating to the effect of nystatin, PMA and MbCD on virus fusion. Syncytium formation between NDV-infected cells was inhibited in COS-7 cells (Fig. 2a) and HeLa cells (Fig. 2b) . Additionally, the drug effect was dose-dependent. Nystatin and PMA showed the highest degree of syncytium reduction in COS-7-infected cells (Fig. 2a) , which was similar to the effect observed with nystatin in HeLa-infected cells (Fig. 2b) . Nevertheless, fusion was reduced to a greater extent by PMA in COS-7-infected cells than in HeLa cells. The inhibitory effect was greatly reduced when drugs were added after virus adsorption (Fig. 2a , indicated by asterisks), thus confirming their effect on virus entry. Unlike data reported for other viruses that enter cells mainly by endocytosis, none of the drugs studied here completely abolished NDV fusion or infectivity at the concentrations assayed. To discard some other drug effects in the cells due to long incubation periods, syncytium formation in NDVinfected HeLa cells was analysed when drugs were removed before virus infection. For PMA and MbCD, similar levels of syncytium inhibition were detected, whereas the degree of inhibition by nystatin was slightly reduced (data not shown). Moreover, cell-cell fusion induced by the paramyxovirus RSV was not abolished by PMA or nystatin treatment of HeLa cells: pretreatment of cells with 10 mM PMA or 10 mg nystatin ml 21 elicited 0 and 8 % fusion inhibition, respectively, as assessed by a syncytium assay (Fig. 3) . These results confirm the specific effect of the drugs.
To test whether the inhibitory effect of the drugs was affected by virus concentration, COS-7 cells were infected with NDV at different concentrations (m.o.i. of 0.1, 1 and 10). Results (Fig. 2c) show that NDV fusion was inhibited by the drugs at the three virus concentrations assayed. Nevertheless, the drug effect was less pronounced at the lowest virus concentration, eliciting approximately 20-30 % fusion inhibition compared with more than 50 % fusion inhibition at m.o.i. of 1 and 10, with almost no difference between the two highest virus concentrations studied. These results suggest that NDV might use endocytic routes of entry more extensively when larger amounts of virus are present, suggesting that endocytosis is a less specific route of entry (DeTulleo & Kirchhausen, 1998; Stuart et al., 2002) and, hence, that other routes are available for the virus. Nevertheless, endocytosis might be used at low virus concentrations, i.e. m.o.i. of 0.1.
The extent of NDV binding to COS-7 cells previously treated with PMA, nystatin, MbCD and chlorpromazine was determined using the spectrofluorimetric assay described in Methods. As can be deduced from the data summarized in Table 1 , pretreatment of cells with PMA and nystatin did not significantly modify the degree of NDV binding to cells, meaning that the inhibition shown in Figs 1 and 2 was not exerted on the virus-cell binding step. Nevertheless, preincubation of cells in the presence of 10 mM MbCD led to a significant reduction in the extent of virus-cell binding, suggesting an important role for cholesterol in virus-cell binding.
Co-localization of NDV and the endocytic pathways
To provide further confirmation that NDV may enter the host cell via endocytic pathways, immunofluorescence labelling with antibodies against the HN protein of NDV and the early endosomal antigen 1 marker protein EEA1 was used together with confocal microscopy. After 30 min of infection, a punctate staining pattern with a strong co-localization of HN protein and EEA1 was found, thus confirming that HN is targeted to early endosomes. (Fig. 4a,  no drug) . No co-localization was observed when cells were pretreated with PMA, nystatin or MbCD, although NDV HN co-localized with EEA1 after chlorpromazine treatment (Fig. 4a) . Co-localization of RSV and EEA1 was not detected at 30 min p.i. (Fig. 4b) .
Effect of pH on NDV-induced cell-cell fusion
Using the spectrofluorimetric technique of R18 dequenching, it has been shown previously (San Roman et al., 1999) that the fusion of NDV with COS-7 cells is enhanced at acidic pH. This effect was confirmed using fluorescence microscopy techniques. The pH dependence of cell-cell fusion induced by NDV was studied. For this, NDV-infected COS-7 cells were used as effector cells and non-infected COS-7 cells were used as target cells. Effector cells were labelled with the green cytoplasmic fluorescent probe CMFDA, whereas target cells were labelled with the red , 10 mM MbCD or 10 mg chlorpromazine ml "1 for 30 min (MbCD) or 45 min (PMA, nystatin and chlorpromazine) and then cells were treated as in (a), except that the drug was removed before virus infection.
cytosolic fluorescent probe CMTPX, as described in Methods. Following this, the two populations of cells were mixed and pre-incubated at different pH values for the indicated times, with an additional 2 h incubation in complete medium (pH 7.4) at 37 uC. Fusion was monitored by aqueous dye transfer redistribution analysis with fluorescence microscopy, scoring those cells showing both red and green fluorescence as fusion-positive events. As seen in Fig. 5 , pre-incubation for 5 min at low pH increased the number of fusion-positive events, pointing to activation at acidic pH. The time dependence of activation at acidic pH is shown in Fig. 6 . Data are from images similar to those shown in Fig. 5 . Fusion is expressed as the number of fusionpositive events over the total number of cells averaged in ten microscopic fields, as detailed in Methods. At the three times assayed, pre-incubation of cells at acidic pH elicited an increase in fusion of more than 20 % compared with preincubation at neutral pH. Additionally, a slight increase in fusion was detected between 1 and 5 min incubation at both acidic and neutral pH values. These data confirm the activation of NDV-triggered membrane fusion at acidic pH.
DISCUSSION
Viruses need to exploit the host cell machinery for their replication and propagation. Although it has been established that the paramyxovirus envelope, including that of NDV, fuses directly with the plasma membrane, it has been suggested previously that, in addition to this route, NDV might penetrate the cell by endocytosis (San Roman et al., 1999) . The aim of the present work was to investigate this issue further and to address the endocytic mechanism(s) of NDV entry using pharmacological agents and co-localization assays. NDV binding, fusion and infection were studied in the presence of drugs known to inhibit particular endocytic routes. The caveolae-pathway inhibitors tested, PMA, nystatin and MbCD, exerted a partial blockade of NDV infectivity and fusion (Figs 1 and 2) , suggesting involvement of the caveolae pathway in NDV entry and the existence of different simultaneous entry pathways. Moreover, when drugs were added after virus adsorption, the inhibitory effect was greatly reduced (Fig. 2a, indicated by asterisks), thus confirming that the drug effect was mainly exerted in the early steps of virus-cell interactions. The lack of an inhibitory effect on NDV infectivity exerted by the clathrin pathway-disturbing drug chlorpromazine (Fig. 1) , together with the absence of the blockage of NDV transfer to endosomes after chlorpromazine treatment observed in our co-localization assays (Fig. 4a) , suggest that NDV does not enter cells via clathrin-mediated endocytosis. Since chlorpromazine is highly toxic, it was not possible to have long periods of incubation with this drug. Accordingly, further experiments should be performed to assess the absence of the role of clathrin in the entry of NDV into cells.
Our binding experiments revealed that the inhibitory effect on NDV fusion and infectivity of the caveolae pathway-disturbing drugs nystatin and PMA took place at a post-binding stage (Table 1) . Nevertheless, when COS-7 cells were treated with the cholesterol-depleting agent MbCD, the binding of NDV to cells was considerably reduced (Table 1) , in contrast to the data reported for other viruses such as poliovirus (Danthi & Chow, 2004) and the effect of the sterol-binding antibiotic nystatin reported here (Table 1) . This suggests that cell-membrane cholesterol is involved in virus-cell interactions at the cell surface, in addition to the interference in the endocytic pathway discussed above. As a possible explanation, NDV receptors might be associated with cholesterol-rich plasma membrane microdomains, such as lipid rafts. Alterations to such structures after drug treatment might modify the accessibility of receptor molecules to the virus or may affect their native conformation. Moreover, modifications of cholesterol levels could alter bilayer fluidity and/or the integrity of membrane lipid microdomains, hindering lateral diffusion within the membrane (Danthi & Chow, 2004) and, consequently, recruitment of the viral receptors and coreceptors needed for optimum virus-cell binding.
The use of endocytic pathways in NDV entry was further assessed by direct examination by confocal microscopy (Fig. 4a) , which confirmed our data concerning drug action on NDV fusion and infectivity discussed above. NDV colocalized with the early endosome marker EEA1 at 30 min p.i. (Fig. 4a, no drug) . The absence of co-localization of HN protein with EEA1 after treatment with caveolae pathway-disturbing drugs further supports the idea that the drug inhibitory effect shown here was related to endocytic entry of the virus. These data suggest that, after internalization, virus particles would be trafficked through early endosomes. In summary, our results suggest that NDV may use the caveolae-mediated endocytic pathway. Additionally, it may be possible that NDV uses other non-clathrin-, noncaveolae-mediated endocytosis routes. As summarized in the Introduction, for most viruses that penetrate the cell through endocytosis, the use of only one specific endocytic pathway has been described, clathrin-or caveolae-dependent. Data are now emerging that support the notion of viruses using more than one pathway for entry. The enterovirus EV-11 uses both the clathrin and caveolae pathways at high m.o.i. (Stuart et al., 2002) ; in addition to clathrin-coated pits, influenza virus may penetrate the cell through undetermined non-clathrin-, non-caveolae-dependent pathways (Sieczkarski & Whittaker, 2002b) or caveolar endocytosis (Nunes-Correia et al., 2004) . SV-40, which represents the prototype of caveolar endocytosis entry, may use an alternative route of entry in the absence of caveolin, in a pathway independent of clathrin and dynamin (Damm et al., 2005) . Epstein-Barr virus (Miller & Hutt-Fletcher, 1992) , herpes simplex virus (Nicola et al., 2003; Milne et al., 2005) , human immunodeficiency virus (Daecke et al., 2005) and Vaccinia virus (Townsley et al., 2006) enter the cell through direct fusion at the plasma membrane or through endocytosis, in most cases in a cell-specific manner. For NDV, our data seem to point to the existence of more than one active entry pathway into a single cell type, i.e. direct fusion with the plasma membrane and caveolae-mediated endocytosis. The type of pathways exploited may be explained in terms of the use of different virus receptors (Sieczkarski & Whittaker, 2002b) . It has been shown previously that NDV binds to different sialic acid compounds such as gangliosides and N-glycoproteins (Ferreira et al., 2004) . The presence of two different sialic acid-binding sites in the NDV receptor-binding protein HN has been reported (Zaitsev et al., 2004) . The pliable catalytic site, site I, exhibits both neuraminidase and receptorbinding activities, whereas the second binding site, site II, shows only receptor-binding activity. Mutations in site II have revealed that it is not essential for virus infection, but enhances it (Bousse et al., 2004) . Certain molecules that interact with HN site I would activate site II and promote continued receptor binding, although binding to site I does not imply binding to site II (Porotto et al., 2006) . The case may be that, once activated, site II would recognize specific receptors for endocytosis. It could also be speculated that a population of site II would bind ligands in the absence of binding to site I, leading to endocytic entry. Future work will address this issue. Another interesting possibility is that endocytic entry might be governed through interaction of the F protein with the cell surface independently of the HN protein (Sergel et al., 2000; Russell et al., 2001; Cobaleda et al., 2002) .
Structurally, the fusion proteins of enveloped viruses have been classified into at least two classes: class I proteins, whose prototype is influenza virus HA protein; and class II proteins, whose prototype is the tick-borne encephalitis virus glycoprotein E (Jardetzky & Lamb, 2004; Schibli & Weissenhorn, 2004; Kielian & Rey, 2006) . The fusion glycoproteins of paramyxoviruses belong to class I. The triggering of class I fusion proteins can be accomplished by lowering the pH (for pH-dependent viruses) or by binding to receptor(s) (for pH-independent viruses). Recently, a third type of activation mechanism has been proposed that combines both of the above mechanisms: an initial triggering of the protein by receptor binding at neutral pH, followed by acidic pH activation (Earp et al., 2003; Mothes et al., 2000; Barnard et al., 2004; Matsuyama et al., 2004) . Additionally, pH-independent viruses that have been thought to fuse directly at the plasma membrane may be internalized through a pH-independent endocytic pathway (Daecke et al., 2005) . Consequently, the pH-independent classification of some viruses might well deserve reappraisal. Here, it has been shown that fusion between NDV-infected and non-infected cells occurs both at acidic and neutral pH (Figs 5 and 6), although a greater degree of fusion is observed at acidic pH. It has been reported previously (San Roman et al., 1999) that incubation of cells with the lysosomotropic weak base ammonium chloride partially prevents NDV from fusing with COS-7 cells. This observation is consistent with pH-dependent virus fusion along the endocytic route. In the present work, the pre-incubation of cells at acidic pH (Fig. 6 ) elicited an increase in fusion of about 20 % compared with controls. This activation occurred at least 1 min after exposure to acidic pH. In addition to NDV, the SER paramyxovirus has a pHdependent entry mechanism (Seth et al., 2003) , exhibiting fusion at acidic pH but, unlike NDV, not at neutral pH. Additionally, cleavage activation of the F protein of the recently emerged Nipah virus and Hendra virus occurs after internalization of the protein by clathrin-mediated endocytosis (Diederich et al., 2005; Meulendyke et al., 2005) . Since low pH does not seem to be a strict requirement for NDV fusion, acidic pH activation would mean the existence of an alternative mechanism to neutral pH activation, as proposed previously (San Roman et al., 1999) . According to our hypothesis, NDV fuses at both neutral and acidic pH, depending on the route of entry. At neutral pH, some viruses bound to the cell surface could become endocytosed and then fusion-activated in the endosome compartments. Several possibilities may be invoked to explain the detected enhancement of NDV fusion at acidic pH (Figs 5 and 6). Thus, it could be argued that triggering of the conformational changes required for fusion might be accelerated at low pH. This would imply that HN fusion promotion activity (Porotto et al., 2003) and/or the population of F that is activated independently of HN (Sergel et al., 2000; Russell et al., 2001; Cobaleda et al., 2002) would be enhanced once the endocytic compartments have been reached. Since paramyxovirus neuraminidases have an acidic optimum pH (4.8-5.5) (Ryan et al., 2006) , an acidic pH in the endosome would enhance the neuraminidase activity of HN at site I and also, hypothetically, the conformational changes of HN required for site II to be activated (Porotto et al., 2006) . Since site II exhibits greater receptor avidity than site I (Porotto et al., 2006) , the increase in virus-receptor contact would be responsible for the higher extent of fusion observed when the pH is lowered experimentally (Figs 5 and 6) . The general conclusion of our work is that NDV would be able to enter and infect cells through different pathways; in addition to direct fusion with the plasma membrane, a certain percentage of virions would be endocytosed to endosomes, where fusion would occur. Our concept of virus entry is becoming increasingly more complex and why and how viruses are able to use different pathways remain open questions. Viruses could have adapted to the multiple mechanisms and pathways that cells have for internalizing different molecules, exploiting different entry routes. Moreover, the same virus may have different preferences, depending on the cell line. Knowledge of virus entry is crucial for the development of antiviral agents, as well as for the use of viruses as tools in gene therapy to deliver genes to cells. The two cell populations were mixed in a proportion of 3 : 1 (effector : target) and co-cultured for 3 h at 37 6C. F protein was then activated proteolytically as described in the text. Immediately after activation, cells were incubated in PBS at pH 5.0 or 7.4 for 5 min. The pH was then returned to around neutral with complete medium and cells were incubated for an additional 2 h at 37 6C. Images were collected using a 406 objective and dye distribution was monitored under an inverted microscope. Rhodamine (left), FITC (middle) and merge (right) images are shown. Fusion-positive events (cells labelled with both dyes) are marked (*) in the merge field. 
